文献速递流行病学与生物统计真实世界研究与卫生经济

利用现有HIV初级卫生系统和社区卫生工作者在非洲开展高血压筛查与治疗的成本效益:一项基于个体的建模研究

Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: An individual-based modeling study.
PubMed 文献 · PLoS Med · 2025-01-24

该建模研究模拟了东部、南部、中部和西部非洲3000种场景下的高血压和心血管疾病,评估将HIV初级保健诊所扩展为慢性病诊所(CCC)及联合社区卫生工作者(CHW)筛查两种策略。结果显示,CCC联合CHW筛查可大幅改善高血压控制并降低心血管疾病发病和死亡,且在62%的场景中具有成本效益。

要点

  • 在45至64岁成人中,CCC策略可将高血压控制率从平均4%提高至14%,联合CHW筛查可进一步提高至44%。
  • CCC策略可减少缺血性心脏病10%、卒中13%、心血管疾病死亡9%;联合CHW筛查分别减少28%、36%和25%。
  • CHW筛查在62%的场景中具有成本效益,CCC在31%的场景中具有成本效益,两者均不具成本效益的场景占7%。

核心结论

  • 利用现有医疗基础设施,通过CHW开展人群高血压筛查并在综合慢性病诊所治疗高血压,预计可降低非洲心血管疾病发病和死亡,且在大多数场景中可能具有成本效益。

研究设计与样本

  • 建模研究,模拟东部、南部、中部和西部非洲3000种场景下的高血压和心血管疾病。
  • 比较两种策略与当前高血压治疗:CCC策略(将HIV初级保健诊所扩展为慢性病诊所,为所有无论HIV状态的人提供高血压治疗)和CHW策略(CCC加上由社区卫生工作者对40岁及以上成人进行人群高血压筛查)。
  • 主要分析采用每避免一个伤残调整生命年(DALY)500美元的成本效益阈值、3%年贴现率和50年时间跨度。
  • 若策略导致最低净DALY,则被认为具有成本效益。

主要发现

  • 在45至64岁成人中,CCC实施可将人群高血压控制率从平均4%(90%范围1%至7%)提高至14%(6%至26%);额外CHW筛查可提高至44%(35%至54%)。
  • 在所有成人中,CCC实施可减少缺血性心脏病(IHD)发病率10%(3%至17%)、卒中13%(5%至23%)、心血管疾病死亡率9%(3%至15%)。
  • CCC联合CHW筛查可减少IHD 28%(19%至36%)、卒中36%(25%至47%)、心血管疾病死亡率25%(17%至34%)。
  • CHW筛查在62%的场景中具有成本效益,CCC在31%的场景中具有成本效益,两者均不具成本效益的场景占7%。
  • 汇总场景后,CCC的增量成本效益比为每避免一个DALY 69美元,在CCC基础上增加CHW筛查为每避免一个DALY 389美元。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular disease (CVD) morbidity and mortality is increasing in Africa, largely due to undiagnosed and untreated hypertension. Approaches that leverage existing primary health systems could improve hypertension treatment and reduce CVD, but cost-effectiveness is unknown. We evaluated the cost-effectiveness of population-level hypertension screening and implementation of chronic care clinics across eastern, southern, central, and western Africa. METHODS AND FINDINGS: We conducted a modeling study to simulate hypertension and CVD across 3,000 scenarios representing a range of settings across eastern, southern, central, and western Africa. We evaluated 2 policies compared to current hypertension treatment: (1) expansion of HIV primary care clinics into chronic care clinics that provide hypertension treatment for all persons regardless of HIV status (chronic care clinic or CCC policy); and (2) CCC plus population-level hypertension screening of adults ≥40 years of age by community health workers (CHW policy). For our primary analysis, we used a cost-effectiveness threshold of US $500 per disability-adjusted life-year (DALY) averted, a 3% annual discount rate, and a 50-year time horizon. A strategy was considered cost-effective if it led to the lowest net DALYs, which is a measure of DALY burden that takes account of the DALY implications of the cost for a given cost-effectiveness threshold. Among adults 45 to 64 years, CCC implementation would improve population-level hypertension control (the proportion of people with hypertension whose blood pressure is controlled) from mean 4% (90% range 1% to 7%) to 14% (6% to 26%); additional CHW screening would improve control to 44% (35% to 54%). Among all adults, CCC implementation would reduce ischemic heart disease (IHD) incidence by 10% (3% to 17%), strokes by 13% (5% to 23%), and CVD mortality by 9% (3% to 15%). CCC plus CHW screening would reduce IHD by 28% (19% to 36%), strokes by 36% (25% to 47%), and CVD mortality by 25% (17% to 34%). CHW screening was cost-effective in 62% of scenarios, CCC in 31%, and neither policy was cost-effective in 7% of scenarios. Pooling across setting-scenarios, incremental cost-effectiveness ratios were $69/DALY averted for CCC and $389/DALY averted adding CHW screening to CCC. CONCLUSIONS: Leveraging existing healthcare infrastructure to implement population-level hypertension screening by CHWs and hypertension treatment through integrated chronic care clinics is expected to reduce CVD morbidity and mortality and is likely to be cost-effective in most settings across Africa.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Hickey MD, Ayieko J, Kabami J, et al. Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: An individual-based modeling study. PLoS Med. 2025. PMID: 39854581. doi:10.1371/journal.pmed.1004531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。